Ipamorelin Pen

Price range: Rp1,200,000.00 through Rp2,600,000.00 ~$72.73–$157.58

Ipamorelin 10mg Pen is a convenient pre-mixed peptide pen commonly used within recovery, wellness, performance, and active lifestyle-focused protocols. Ready to use with no mixing required.

💉 Ready To Use | ⚡ Recovery Support | 💪 Performance Focus | 🚚 Same-Day Bali Delivery

10 Needles + 10 Alcohol pads included.
Description

Ipamorelin 10 mg Pen

Product Description

Ipamorelin is a selective growth hormone secretagogue peptide from the GHRP family, studied primarily for its interaction with the growth hormone secretagogue receptor (GHS-R1a).

By activating ghrelin-sensitive receptors within the pituitary and related neuroendocrine pathways, Ipamorelin has been investigated for its ability to stimulate pulsatile endogenous growth hormone (GH) release rather than supplying growth hormone directly.

Compared with earlier growth hormone-releasing peptides, Ipamorelin is particularly interesting because of its relatively selective receptor profile and the lower cortisol and prolactin responses reported in experimental research. Pasted text

Research areas include growth hormone signalling, IGF-1 biology, recovery pathways, endocrine ageing, sleep-associated hormone secretion, metabolism, and tissue repair.

The Atlas Longevity Ipamorelin pen contains 10 mg in a 3 mL pre-mixed cartridge with 300 total units/clicks.

Ipamorelin remains an investigational research peptide and should not be presented as an approved treatment for growth hormone deficiency, muscle growth, anti-ageing, sleep disorders, or other medical conditions.


Clinical / Research Status

Ipamorelin has been investigated in animal models, laboratory studies, and exploratory human research.

The supplied material characterizes the evidence base as primarily preclinical with limited exploratory human data. Pasted text

Evidence Type Status Based on Supplied Material
Human controlled research Limited / exploratory
Human observational research Limited
Animal research Yes
In-vitro research Yes
Regulatory therapeutic approval Not established

Some human studies demonstrate pharmacological activity, but this should not be confused with regulatory approval or proven effectiveness for performance, recovery, anti-ageing, or body-composition purposes.


Evidence Type

The supplied research includes:

  • pituitary-cell studies;
  • healthy adult pharmacology studies;
  • aged-animal models;
  • postoperative gastrointestinal research;
  • bone-related animal models;
  • catabolic-state animal studies;
  • in-vitro somatotroph assays;
  • exploratory human growth hormone research. Pasted text

Evidence quality and clinical relevance differ considerably across these research areas.


Mechanism of Action

Ipamorelin primarily acts as an agonist of the GHS-R1a receptor, commonly known as the growth hormone secretagogue or ghrelin receptor.

Activation of this receptor can stimulate pituitary somatotroph cells to release endogenous growth hormone in a pulsatile pattern.

This is different from administering growth hormone directly.

The supplied material describes Ipamorelin as being comparatively selective for GH stimulation, with less activation of cortisol- and prolactin-related pathways than some earlier GHRPs. Pasted text

Increased growth hormone signalling can subsequently influence hepatic production of insulin-like growth factor-1 (IGF-1), creating downstream effects on cellular growth, protein metabolism, connective-tissue biology, and metabolic signalling.

The extent and clinical significance of these effects depend on the model studied.


Potential Benefits / Research Areas

Endogenous Growth Hormone Research

Ipamorelin is primarily investigated for its ability to stimulate the body’s own growth hormone secretion.

Rather than replacing GH directly, the compound interacts with growth hormone secretagogue receptors to influence endogenous pituitary release.

This makes Ipamorelin useful in research examining GH pulse amplitude, timing, endocrine feedback, and downstream IGF-1 signalling. Pasted text

This mechanism does not establish Ipamorelin as an approved growth hormone treatment.

Recovery and Tissue-Repair Signalling

Growth hormone and IGF-1 participate in several processes involved in tissue adaptation and repair.

Ipamorelin research therefore includes experimental investigation of:

  • protein metabolism;
  • connective-tissue biology;
  • muscle-repair pathways;
  • structural tissue adaptation;
  • regenerative signalling. Pasted text

These mechanisms should not be interpreted as guaranteed improvements in human recovery or muscle gain.

Endocrine Feedback Research

A major research distinction between secretagogues and externally administered growth hormone is the way they interact with existing endocrine signalling.

The supplied source discusses Ipamorelin in relation to maintaining endogenous hypothalamic-pituitary regulation while stimulating pituitary GH release. Pasted text

The long-term clinical implications of this distinction are not established by the supplied information.

Selective Growth Hormone Secretagogue Research

Earlier growth hormone-releasing peptides can affect several endocrine pathways.

Ipamorelin was developed and studied for a more selective secretagogue profile.

Experimental research suggests that it can stimulate GH with relatively limited effects on ACTH, cortisol, and prolactin compared with some less-selective GHRPs. Pasted text

“More selective” should not be interpreted as having no endocrine effects or no potential risks.

Sleep-Associated Hormone Research

Growth hormone secretion follows a natural pulsatile rhythm, with significant secretion associated with deep sleep.

Ipamorelin has therefore been investigated in research examining nocturnal GH pulses, endocrine timing, sleep-associated hormone biology, and recovery signalling. Pasted text

The supplied evidence does not establish Ipamorelin as a treatment for insomnia or poor sleep quality.

IGF-1 Signalling

Growth hormone can stimulate hepatic production of IGF-1.

This places Ipamorelin within research involving the broader GH–IGF-1 axis and downstream biological pathways related to:

  • cellular growth;
  • protein metabolism;
  • tissue repair;
  • skeletal biology;
  • metabolic signalling. Pasted text

Effects on these pathways do not guarantee anabolic or performance outcomes in humans.

Age-Associated GH Research

Endogenous growth hormone secretion can change with age.

Ipamorelin has therefore been investigated in experimental models examining age-associated changes in GH pulsatility and endocrine signalling. Pasted text

This should not be interpreted as evidence that Ipamorelin reverses ageing or restores youthful physiology in humans.

Gastrointestinal Motility Research

The supplied research also references human clinical investigation involving postoperative ileus and gastrointestinal motility. Pasted text

This represents a distinct clinical research area and should not be used as evidence for muscle growth, longevity, recovery, or other unrelated claims.


Research Data

Study / Model Reported Finding
Rat pituitary-cell research Increased GH release through GHS-R1a activation with limited cortisol/prolactin response
Healthy adult pharmacology study Dose-related increases in circulating GH and IGF-1 were reported
Aged rat model Changes in pulsatile GH secretion and lean-tissue measurements
Postoperative ileus clinical research Changes in gastrointestinal motility and time to bowel-function recovery
Experimental osteopenia model Changes in bone mineral density and trabecular architecture
Catabolic rodent model Reduced nitrogen loss and changes in protein-synthesis/recovery markers
In-vitro somatotroph research Selective GH-secretagogue activity was observed

The evidence includes both human and preclinical research, but animal or cellular findings should not be represented as established human benefits. Pasted text


Potential Stack / Combination Research

The supplied reference discusses experimental combinations involving Ipamorelin with:

  • CJC-1295;
  • BPC-157;
  • Tesamorelin;
  • MK-677. Pasted text

The proposed research rationale generally involves combining different pathways related to growth hormone release, GHRH signalling, tissue repair, or ghrelin-receptor activity.

However, the supplied information does not establish validated human safety, efficacy, compatibility, or optimal dosing for these combinations.

Atlas Longevity therefore does not present them as recommended stacks.


Atlas Longevity Ipamorelin Pen Dosage / Click Chart

The Atlas Longevity Ipamorelin pen contains:

10 mg Ipamorelin

3 mL cartridge volume

300 total clicks

1 click = 0.01 mL

Maximum selectable dial amount = 60 clicks

Pen Specification

Pen Strength Volume Concentration Amount Per Click
10 mg 3 mL ≈3.333 mg/mL ≈0.0333 mg / 33.3 mcg

Concentration Calculation

10 mg ÷ 3 mL = 3.3333 mg/mL

Rounded:

≈3.333 mg/mL

Amount Per Click

10 mg ÷ 300 clicks = 0.033333 mg per click

Therefore:

1 click ≈0.0333 mg

or:

≈33.3 mcg Ipamorelin


Ipamorelin Click Conversion Chart

Clicks Volume Ipamorelin Amount
1 0.01 mL ≈0.0333 mg / 33.3 mcg
3 0.03 mL 0.100 mg / 100 mcg
5 0.05 mL ≈0.1667 mg / 166.7 mcg
6 0.06 mL 0.200 mg / 200 mcg
9 0.09 mL 0.300 mg / 300 mcg
10 0.10 mL ≈0.333 mg / 333 mcg
15 0.15 mL 0.500 mg / 500 mcg
20 0.20 mL ≈0.667 mg / 667 mcg
30 0.30 mL 1.000 mg
40 0.40 mL ≈1.333 mg
50 0.50 mL ≈1.667 mg
60 0.60 mL 2.000 mg

Useful Conversions

  • 3 clicks = 0.10 mg / 100 mcg
  • 6 clicks = 0.20 mg / 200 mcg
  • 9 clicks = 0.30 mg / 300 mcg
  • 15 clicks = 0.50 mg / 500 mcg
  • 30 clicks = 1 mg
  • 60 clicks = 2 mg

The maximum selectable amount in one dial operation is:

60 clicks = 0.60 mL = 2 mg Ipamorelin

This is a mathematical concentration conversion, not a dosing recommendation.


Protocol / Dosage Information

The supplied source discusses experimental quantities ranging from approximately 0.10 mg to 0.50 mg within several proposed research protocols. Pasted text

Those original click calculations were based on a different 2 mL formulation, so they should not be copied into the Atlas Longevity system.

Using the Atlas 10 mg / 3 mL / 300-click pen:

Source-Referenced Amount Atlas Pen Conversion
0.10 mg / 100 mcg 3 clicks
0.15 mg / 150 mcg ≈4.5 clicks*
0.20 mg / 200 mcg 6 clicks
0.25 mg / 250 mcg ≈7.5 clicks*
0.30 mg / 300 mcg 9 clicks
0.40 mg / 400 mcg 12 clicks
0.50 mg / 500 mcg 15 clicks

*These values fall between whole pen units and therefore cannot be selected exactly using whole clicks.

These conversions are provided only to translate quantities appearing in the supplied research material into the Atlas pen concentration.

They do not establish a recommended human dose, timing schedule, administration frequency, treatment duration, cycling strategy, or therapeutic protocol.


Possible Side Effects

The supplied material describes Ipamorelin as comparatively well tolerated in experimental settings, but this does not establish complete long-term safety.

Reported effects include:

  • localized redness or irritation;
  • injection-site swelling;
  • temporary headache;
  • light-headedness;
  • flushing or warmth;
  • temporary appetite increase;
  • fatigue or drowsiness;
  • mild fluid retention;
  • tingling or numbness in the extremities at higher exposures. Pasted text

The source reports relatively limited effects on cortisol and prolactin in the research it references.

However, that should not be interpreted as proof that these pathways can never be affected.

Long-term safety remains incompletely characterized, including potential effects relating to:

  • prolonged GH / IGF-1 elevation;
  • glucose metabolism;
  • fluid balance;
  • endocrine signalling;
  • contraindications;
  • medication interactions;
  • reproductive health;
  • combination protocols.

Product Attributes

Attribute Information
Compound Name Ipamorelin
CAS Number 170851-70-4
Molecular Formula C38H49N9O5
Amino Acid Sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2
Molecular Weight 711.86 g/mol
PubChem CID 9831659
Half-Life listed by source Approximately 2 hours
Synonyms NNC 26-0161, Ipamorelin acetate
Compound Type Synthetic selective growth hormone secretagogue peptide
Primary Target GHS-R1a / ghrelin receptor
Research Focus Growth hormone signalling, recovery, metabolism and endocrine ageing research

These specifications are reported in the supplied reference material.

Included in the Box

Each Atlas Longevity product is carefully packed to support secure storage, clean handling, and convenient research use. Inside the package, you’ll find the essential items needed for organized laboratory handling:

  • 1× Ready-to-Use Injection Pen
  • 10× Ultra-Fine Needles (33G, 4 mm)
  • 10× Alcohol Prep Pads
  • Protective Foam Insert to help keep the pen secure during transport
  • Quick-Reference Instruction Panel inside the packaging
  • Tamper-Evident Security Seal for added package protection

Each component is arranged in a clean, protective presentation designed to keep the product secure and easy to access.

Storage

Storage conditions should follow the instructions supplied specifically with the Atlas Longevity Ipamorelin formulation.

The reference product provides refrigeration and stability specifications for its own pre-mixed formulation. Those claims should not automatically be transferred to Atlas Longevity without formulation-specific stability data.

Follow the temperature requirements, light-protection guidance, handling instructions, and shelf-life information shown on the Atlas Longevity product label or accompanying documentation.

 


Frequently Asked Questions

What is Ipamorelin?

Ipamorelin is a synthetic growth hormone secretagogue peptide that primarily activates the GHS-R1a receptor.

It is investigated for its ability to influence endogenous growth hormone secretion while showing a comparatively selective endocrine profile in experimental research. Pasted text

Is Ipamorelin growth hormone?

No.

Ipamorelin is not human growth hormone.

It is a growth hormone secretagogue, meaning it is studied for its ability to stimulate endogenous GH release from the pituitary.

How does Ipamorelin work?

Ipamorelin activates the GHS-R1a / ghrelin receptor.

This can stimulate pulsatile growth hormone release, which can subsequently influence downstream IGF-1 signalling. Pasted text

How is Ipamorelin different from GHRP-6?

Both compounds are growth hormone secretagogues acting through ghrelin-related pathways.

However, Ipamorelin is researched for greater receptor selectivity, whereas GHRP-6 has a broader endocrine and appetite-related signalling profile.

This distinction is based on experimental pharmacology and should not be interpreted as meaning Ipamorelin is risk-free.

What is Ipamorelin researched for?

Research areas include:

  • growth hormone secretion;
  • GH pulsatility;
  • IGF-1 signalling;
  • endocrine ageing;
  • recovery biology;
  • protein metabolism;
  • bone-related research;
  • gastrointestinal motility;
  • sleep-associated hormone patterns.

Evidence strength varies between these areas.

Has Ipamorelin been studied in humans?

Yes.

The supplied source identifies exploratory human pharmacology and clinical research alongside animal and laboratory studies. Pasted text

However, human investigation does not mean Ipamorelin is approved for anti-ageing, muscle growth, recovery, or performance use.

How much Ipamorelin is in each Atlas Longevity pen?

Each Atlas Longevity Ipamorelin pen contains:

10 mg in 3 mL.

What is the concentration of the Ipamorelin pen?

The concentration is:

10 mg ÷ 3 mL = approximately 3.333 mg/mL

How many clicks are in the pen?

Each Atlas Longevity pen contains:

300 total clicks / units

with:

1 click = 0.01 mL

How much Ipamorelin is in one click?

Each click contains approximately:

0.0333 mg

or:

33.3 mcg Ipamorelin

How many clicks equal 100 mcg?

3 clicks = 100 mcg / 0.10 mg.

How many clicks equal 200 mcg?

6 clicks = 200 mcg / 0.20 mg.

How many clicks equal 300 mcg?

9 clicks = 300 mcg / 0.30 mg.

How many clicks equal 500 mcg?

15 clicks = 500 mcg / 0.50 mg.

These are concentration calculations rather than dosing recommendations.

What is the maximum selectable amount on the Ipamorelin pen?

The maximum single dial selection is:

60 clicks

which equals:

0.60 mL

and:

2 mg Ipamorelin

This represents the mechanical range of the pen rather than a recommended amount.

How long does an Ipamorelin pen last?

The full pen contains:

300 clicks and 10 mg Ipamorelin.

The number of administrations depends entirely on the number of clicks selected each time.

For cartridge-capacity calculations only:

  • 3 clicks at a time = 100 administrations
  • 6 clicks at a time = 50 administrations
  • 10 clicks at a time = 30 administrations
  • 15 clicks at a time = 20 administrations
  • 30 clicks at a time = 10 administrations
  • 60 clicks at a time = 5 administrations

These examples describe pen capacity rather than a research protocol.

Does the medication disappear when the dial returns to zero?

No.

After administration, the dial returns to zero while the remaining formulation stays inside the cartridge.

The pen continues to contain the unused Ipamorelin until its 300 total units have been used.

Does Ipamorelin increase cortisol or prolactin?

The supplied research describes Ipamorelin as producing comparatively limited cortisol and prolactin responses relative to some earlier GHRPs. Pasted text

That should not be interpreted as proof that these hormones can never change.

Does Ipamorelin improve sleep?

Ipamorelin is researched in relation to nocturnal growth hormone secretion because GH naturally follows sleep-associated patterns.

However, the supplied evidence does not establish Ipamorelin as an approved treatment for insomnia or sleep disorders.

Can Ipamorelin be combined with CJC-1295?

The supplied source discusses CJC-1295 + Ipamorelin as an experimental combination because the compounds act through complementary GHRH and ghrelin-related signalling pathways. Pasted text

The supplied information does not establish validated human safety, efficacy, or optimal dosing for this combination.

Is there an established human Ipamorelin dosage?

The supplied material describes experimental quantities used in research, but it does not establish a universally accepted or approved human therapeutic dosing standard.

The Atlas click chart therefore represents concentration mathematics only, not medical dosing guidance.

How should the Atlas Longevity Ipamorelin pen be stored?

Follow the storage instructions provided with the actual Atlas Longevity formulation.

The competitor product’s refrigeration and stability specifications relate to its own formulation and should not automatically be applied to Atlas without product-specific stability evidence.

Key Benefits
  • Supports fat metabolism
  • Supports body composition
  • Performance-focused compound
  • Easy-to-use pen format
  • No mixing required
Delivery in Bali

We offer fast and discreet delivery across Bali.

Around Canggu
100,000 IDR
Delivery within 1–5 hours of order

Other Areas of Bali
200,000 IDR
Delivery within 1–5 hours of order

✔ Discreet packaging
✔ Same-day delivery available

Why Atlas Longevity
  • Trusted suppliers
  • Quality-controlled products
  • Fast and discreet delivery
  • Personalised guidance available